Clinical Trial Update: Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction [Phase 4]

View source ↗

Summary

Results from a Phase 4 clinical trial evaluating a PDE5 inhibitor for erectile dysfunction have been posted. The sponsor is VIVUS LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• PDE5 inhibitor (unspecified)

Snippet

Sponsor: VIVUS LLC | Conditions: Erectile Dysfunction | Phase 4 | Status: COMPLETED | Results posted: 2014-10-27